To evaluate the efficacy and safety of dasotraline (4mg/day and 6 mg/day) compared with placebo in adult subjects with ADHD as measured by change from baseline at Week 8 in ADHD symptoms assessed using the ADHD Rating Scale Version IV (ADHD RS-IV) with adult prompts total score.